Explore professionally built ETF model portfolios. Discover now →

XHEvsARKGETF Comparison

ETF 1
XHE

State Street SPDR S&P Health Care Equipment ETF

This fund is part of
US Health Care
-2.15%
VS
ETF 2
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
-0.93%

State Street SPDR S&P Health Care Equipment ETF (XHE) belongs to the US Health Care segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. XHE's top 2 sector exposures are Healthcare and Finance. In contrast, ARKG's top sector exposures are Healthcare. XHE is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.75% for ARKG. XHE is up 4.83% year-to-date (YTD) with +$13M in YTD flows. ARKG performs better with 60.61% YTD performance, and +$136M in YTD flows. Run a side-by-side ETF comparison of XHE and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHE vs ARKG performance and flow charts

Performance

0510%Aug 10Aug 17Aug 24Aug 31Sep 7

Cumulative Flows

-50 M0 M50 M100 MAug 10Aug 17Aug 24Aug 31Sep 7

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 09/08/2026
1M3MYTD1Y3Y5Y
Perf.
XHE
ARKG
-2.01%+5.74%
+13.88%+41.47%
+4.83%+60.61%
+11.92%+84.14%
+12.15%+50.72%
-30.36%-43.73%
Flows
XHE
ARKG
+$5M+$110M
+$10M+$210M
+$13M+$136M
+$2M+$151M
-$264M-$431M
-$380M-$2.19B
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHE
ARKG
+24.33%+43.03%
+22.79%+44.26%
+22.22%+43.95%
+24.83%+46.35%
Max drawdown
XHE
ARKG
-4.79%-13.89%
-18.20%-27.52%
-24.35%-46.41%
-49.72%-78.11%
Max drawdown duration
XHE
ARKG
11d32d
207d126d
565d882d
1826d1825d
Trading data

Create an account to view trading data

Join for free
XHE
ARKG
Last sale
9/9/2026 at 1:30 PM
$91.41
$46.31
Previous close
09/08/2026
$92.32
$46.85
Consolidated volume
09/08/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of August 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
XHE
ARKG
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 9/9/2026 at 1:30 PM
Live
Closed
XHE
ARKG
Last price
$91.41
$46.31
1D performance
-0.99%
-1.15%
AuM$175.52 M$1.99 B
E/R0.35%0.75%
Characteristics
XHE
ARKG
Management strategyPassiveActive
ProviderState Street Investment ManagementArk Investment
BenchmarkS&P Health Care Equipment Select Industry Index-
N° of holdings6631
Asset classEquities-
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 26, 2011April 2, 2019
ESGNoNo
Advertisement
Exposure

Countries

XHE
USA
93.56%
Other
6.44%
ARKG
USA
88.43%
Other
11.57%

Sectors

XHE
Healthcare
98.72%
Other
1.28%
ARKG
Healthcare
97.99%
Other
2.01%
Advertisement

Diversification

XHE

Total weight of top 15 holdings out of 15

30.19%
ARKG

Total weight of top 15 holdings out of 15

75.55%

Top 15 holdings

Data as of July 31, 2026
XHE
AtriCure, Inc.
2.14%
Glaukos Corp.
2.13%
Dentsply Sirona, Inc.
2.08%
Enovis Corp.
2.07%
Integer Holdings Corp.
2.07%
Butterfly Network, Inc.
2.06%
Neogen Corp.
2.05%
Artivion, Inc.
2.05%
Baxter International, Inc.
2.01%
CONMED Corp.
1.99%
Merit Medical Systems, Inc.
1.98%
QuidelOrtho Corp.
1.94%
ICU Medical, Inc.
1.88%
Tandem Diabetes Care, Inc.
1.88%
Inspire Medical Systems, Inc.
1.85%
ARKG
10X Genomics, Inc.
9.41%
Twist Bioscience Corp.
7.74%
Tempus AI, Inc.
6.57%
CRISPR Therapeutics AG
6.30%
Personalis, Inc.
5.48%
Absci Corp.
5.15%
Guardant Health, Inc.
4.75%
Illumina, Inc.
4.75%
Eli Lilly & Co.
4.69%
CareDx, Inc.
4.31%
Natera, Inc.
4.14%
Beam Therapeutics, Inc.
3.78%
Compass Pathways Plc
3.26%
Recursion Pharmaceuticals, Inc.
2.63%
Adaptive Biotechnologies Corp.
2.58%
Frequently asked questions about XHE and ARKG

How have the XHE and ARKG ETFs performed in 2026?

As of September 8, 2026, XHE is up 4.83% year-to-date (YTD), while ARKG has returned 60.61%. That puts ARKG better performer ahead so far this year.

Which ETF is attracting more investor money: XHE or ARKG?

Year-to-date, the XHE ETF saw +$13M in flows, compared to +$136M for ARKG.

Which ETF is more volatile: XHE or ARKG?

Over the past year, XHE had a volatility of 22.79%, while ARKG experienced 44.26%.

Which ETF is bigger: XHE or ARKG?

As of September 8, 2026, XHE holds $175.52 M in assets under management (AUM), while ARKG manages $1.99 B.

What sectors do the XHE and ARKG ETFs invest in?

XHE leans toward sectors like Healthcare. Meanwhile, ARKG focuses on Healthcare.

What are the top holdings of the XHE ETF and ARKG ETF?

XHE top holdings include AtriCure, Inc., Glaukos Corp. and Dentsply Sirona, Inc.. ARKG holds in its top three: 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc..

Which ETF is more diversified: XHE or ARKG?

XHE holds 66 securities with 30.19% of its assets in the top 15. ARKG has 31 securities and a top 15 weight of 75.55%.

Advertisement
Latest news about XHE & ARKG
Advertisement
Advertisement
ETF Comparison Tool

Have you tried our ETF Compare tool?

Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.